Wednesday - June 03, 2026

Category Archives: Science

Xerostomia Market is Expected to Witness Significant Growth by 2036 Due to Rising Disease Burden and Emerging Novel Therapies | DelveInsight

The market dynamics for Xerostomia are anticipated to witness notable growth driven by the increasing prevalence of xerostomia associated with aging populations, rising polypharmacy use, increasing cases of Sjögren’s syndrome, growing head and neck cancer survivorship, and improved awareness regarding … Continue reading →

Basal Cell Carcinoma Market is Expected to Witness Significant Growth by 2036 Due to Rising Disease Burden and Emerging Novel Therapies | DelveInsight

The market dynamics for Basal Cell Carcinoma (BCC) are anticipated to witness notable growth driven by the increasing incidence of BCC, heightened UV exposure, aging population, growing awareness regarding early diagnosis, and the launch of emerging therapies. Additionally, the development … Continue reading →

Food Allergy Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Food Allergy Pipeline Insight 2026” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in the Food Allergy pipeline landscape. It covers the Food Allergy pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Epidermolysis Bullosa Treatment Pipeline Shows Strong Momentum as 18+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Epidermolysis Bullosa Pipeline Insight, 2026” report provides comprehensive insights about 18+ companies and 22+ pipeline drugs in Epidermolysis Bullosa pipeline landscape. It covers the Epidermolysis Bullosa pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Cutaneous T-Cell Lymphoma Clinical Trial Pipeline Expands as 22+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Cutaneous T-cell lymphoma Pipeline Insight 2026” report provides comprehensive insights about 22+ companies and 25+ pipeline drugs in the Cutaneous T-cell lymphoma pipeline landscape. It covers the Cutaneous T-Cell Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading →

Endometrial Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 50+ Key Companies | DelveInsight

DelveInsight’s, “Endometrial Cancer Pipeline Insight, 2026” report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in Endometrial Cancer pipeline landscape. It covers the Endometrial Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Pancreatic Cancer Clinical Trial Pipeline Gains Momentum: 170+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Pancreatic Cancer Pipeline Insight 2026” report provides comprehensive insights about 170+ companies and 200+ pipeline drugs in Pthe ancreatic Cancer pipeline landscape. It covers the Pancreatic Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Idiopathic Membranous Nephropathy Therapeutics Market Size (7MM) was found to be ~USD 130 Million in 2025 and It is projected to grow at a CAGR of 8.2% by 2036, estimates DelveInsight

DelveInsight’s “Idiopathic Membranous Nephropathy Market Insights, Epidemiology, and Market Forecast-2036” report delivers an in-depth understanding of Idiopathic Membranous Nephropathy, historical and forecasted epidemiology, as well as the Idiopathic Membranous Nephropathy market trends in the United States, EU4 (Germany, Spain, Italy, … Continue reading →

Industrial Valve Supplier Anix Valve USA Continues to Lead the Market with Premium Stainless and Carbon Steel Valve Solutions

Leading industrial valve supplier Anix Valve USA reinforces its commitment to quality and innovation by offering an expansive inventory of industrial valves, fittings, and actuators to OEM customers, distributors, and global industries. HOUSTON, TX – May 29, 2026 – As a … Continue reading →